Home › Funds › Two Sigma Investments › VERA
Two Sigma Investments position in VERA
VERA THERAPEUTICS INC · Health Care
Latest position (Q2 2026)104.17K sh
Reported value held$4.47M
Portfolio Weight0.00%
First reportedQ4 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 17.02K | $329.28K | New |
| Q1 2023 | 47.01K | $364.83K | Add |
| Q2 2023 | 33.20K | $532.86K | Reduce |
| Q3 2023 | 100.56K | $1.38M | Add |
| Q4 2023 | 101.29K | $1.56M | Add |
| Q1 2024 | 141.35K | $6.10M | Add |
| Q2 2024 | 157.48K | $5.70M | Add |
| Q3 2024 | 48.55K | $2.15M | Reduce |
| Q4 2024 | 41.45K | $1.75M | Reduce |
| Q1 2025 | 9.55K | $229.41K | Reduce |
| Q1 2025 | 9.55K | $229.41K | Reduce |
| Q2 2025 | 129.13K | $3.04M | Add |
| Q2 2025 | 129.13K | $3.04M | Add |
| Q3 2025 | 171.66K | $4.99M | Add |
| Q4 2025 | 209.95K | $10.63M | Add |
| Q1 2026 | 210.15K | $8.45M | Hold |
| Q2 2026 | 104.17K | $4.47M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VERA
- BlackRock Inc 5.75M sh · $246.64M · Q2 2026
- Vanguard Group 3.57M sh · $180.81M · Q4 2025
- Morgan Stanley 2.80M sh · $120.12M · Q2 2026
- Fidelity Management & Research (FMR) 2.77M sh · $119.04M · Q2 2026
- Geode Capital Management 1.69M sh · $72.64M · Q2 2026
- Goldman Sachs Group 1.38M sh · $59.25M · Q2 2026
- Deutsche Bank AG 1.10M sh · $47.29M · Q2 2026
- Bank of America Corp 590.10K sh · $25.32M · Q2 2026
- Northern Trust Corp 581.13K sh · $24.94M · Q2 2026
- Charles Schwab Investment Management 545.01K sh · $23.39M · Q2 2026
- Balyasny Asset Management 374.95K sh · $16.09M · Q2 2026
- Renaissance Technologies 279.53K sh · $11.99M · Q2 2026